Skip to main content
OpenTrials
Completed

NCT Number: NCT05850013

The Measurement of Vital Signs in Children by Lifelight® Software in Comparison to the Standard of Care

A prospective basic science study for collection of training and testing data for development of Lifelight® Junior

Completed

Looking for future studies?

Notify Me

Key information

About this study

This study will be hospital-based, including paediatric emergency department (PED), inpatient wards and outpatient departments).

The participants will have their vital signs (such as heart rate, respiratory rate, oxygen saturation, blood pressure and temperature) measured using standard-of-care methods. Concurrent with this, videos of the participants' face/torso, and audio of the sounds made by the participants (cry, wheeze, cough) will be recorded. These data will later be used to train the Lifelight® Junior algorithms so that the technology can help in detection of illness and deterioration in children.

Primary Objective Collect the data needed to develop Lifelight® Junior so that it can measure the heart rate, respiratory rate and oxygen saturation of children.

Secondary Objective

  • Assess the feasibility of developing other (direct or indirect) measurement functions in Lifelight® Junior, including temperature, blood pressure, heart rate variability and audio analysis (cry, wheeze, cough).
  • Evaluate the impact of subject-specific variables on the vital sign measurements e.g., medication, cosmetics, facial/body hair and skin tone.
  • Obtain data to understand patient and parent/guardian/carer vital sign measurement habits and preferences
  • Assess the usability of Lifelight® Junior for measuring vital signs in children

To ensure the study collects data that can train Lifelight® Junior in an efficient way, the recruitment should be divided as follows:

  • At least 12% of study participants should fall into each of the following age bands:
  • Age 0-1
  • Age 1-2
  • Age 2-5
  • Age 5-11
  • Age 11-14
  • Age 14-18
  • At least 40% of the study participants shall be male and at least 40% shall be female.
  • At least 40% of the study participants shall be each of the following:
  • Febrile (≥ 38°C) measured how?
  • Afebrile
  • Ill (as judged by the clinical staff), of whom at most 50% shall have an acute respiratory illness e.g., bronchiolitis, asthma, viral induced wheeze, pneumonia, croup, etc.
  • Well, including children with a minor injury

Ideally, 15% of participants should have a Fitzpatrick skin tone of 4, 5 or 6 First reference to this - need to bring it in earlier and to reference it. However, this is not a hard target as achieving this figure is dependent on the demographic diversity of the study region.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Children (0-18 years old) attending the paediatric ED or who are inpatients on the paediatric wards at STSFT

Exclusion criteria

  • Critically ill children (judged so by treating physicians), including unconscious children
  • Children who are non-compliant in terms of excessive movement during the measurement
  • Children of parents/guardians/carers who are non-English speakers

Treatment and study plan

Lifelight Junior

Device

Lifelight® is an app developed by xim that measures VS including heart rate, respiratory rate and blood pressure. All you need to do to have these vital signs measured is look at your smartphone or tablet camera for 20-40 seconds. The app has used data from over 1 million heartbeats to learn how to measure these vital signs in adults. The technology is already available for doctors and nurses to use with adult patients in some specific scenarios

Primary outcomes

  1. Overall outcome measure

    Time frame: 6 months

    Train Lifelight algorithms across more extensive paediatric clinical ranges in 500 subjects

  2. Heart rate

    Time frame: 6 months

    The following accuracy metrics are indicative minimum performance requirements for Lifelight® Junior. VISION-Junior should progress the technology towards these performance targets:

    • Heart rate

    o Root mean square error of 5 bpm or lower

  3. Respiratory rate

    Time frame: 6 months

    The following accuracy metrics are indicative minimum performance requirements for Lifelight® Junior. VISION-Junior should progress the technology towards these performance targets:

    • Respiratory rate

    o Maximum error of 5 breaths per minute for 100% of the measurements

  4. Oxygen saturation level (percentage)

    Time frame: 6 months

    The following accuracy metrics are indicative minimum performance requirements for Lifelight® Junior. VISION-Junior should progress the technology towards these performance targets:

    • Oxygen saturation

    o Maximum error tolerance of 4%.

Sponsors and collaborators

Lead sponsor

Xim Limited

Industry

Collaborators

  • Mind Over Matter Medtech Ltd
  • South Tyneside and Sunderland NHS Foundation Trust

Registry information

Official study title

The Measurement of Vital Signs in Children by Lifelight® Software in Comparison to the Standard of Care The VISION-Junior Study

Acronym: VISION-Jr

Important dates

Study start
2023
Primary completion
2023
Study completion
2024
First posted
May 9, 2023
Registry last updated
Jul 18, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.